| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Diseases | 5 | 2022 | 382 | 0.850 |
Why?
|
| Colitis | 6 | 2022 | 159 | 0.820 |
Why?
|
| Cholestasis | 3 | 2022 | 165 | 0.760 |
Why?
|
| Liver | 4 | 2025 | 1799 | 0.490 |
Why?
|
| Colitis, Ulcerative | 4 | 2022 | 216 | 0.490 |
Why?
|
| Liver Transplantation | 5 | 2025 | 1132 | 0.440 |
Why?
|
| Argininosuccinate Lyase | 3 | 2021 | 62 | 0.420 |
Why?
|
| Urea Cycle Disorders, Inborn | 3 | 2025 | 83 | 0.410 |
Why?
|
| Colon | 3 | 2021 | 361 | 0.370 |
Why?
|
| Intestinal Mucosa | 5 | 2021 | 765 | 0.350 |
Why?
|
| Graft Rejection | 3 | 2024 | 560 | 0.350 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2022 | 328 | 0.300 |
Why?
|
| Trichosporonosis | 2 | 2018 | 8 | 0.280 |
Why?
|
| Liver Cirrhosis | 3 | 2025 | 901 | 0.270 |
Why?
|
| Enterocytes | 2 | 2021 | 68 | 0.270 |
Why?
|
| Biopsy | 6 | 2025 | 1252 | 0.250 |
Why?
|
| Pilomatrixoma | 2 | 2015 | 4 | 0.220 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2021 | 23 | 0.210 |
Why?
|
| Interleukin-15 | 1 | 2025 | 104 | 0.210 |
Why?
|
| Child | 19 | 2025 | 26307 | 0.200 |
Why?
|
| Gastritis | 2 | 2019 | 372 | 0.200 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2022 | 152 | 0.200 |
Why?
|
| Fatty Liver | 1 | 2025 | 220 | 0.190 |
Why?
|
| Intestines | 3 | 2021 | 592 | 0.190 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2021 | 125 | 0.190 |
Why?
|
| Goblet Cells | 2 | 2021 | 104 | 0.190 |
Why?
|
| Alagille Syndrome | 1 | 2022 | 54 | 0.180 |
Why?
|
| Mutation | 4 | 2018 | 6194 | 0.180 |
Why?
|
| Enterocolitis | 1 | 2022 | 28 | 0.180 |
Why?
|
| Pleural Effusion | 1 | 2022 | 106 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 2353 | 0.180 |
Why?
|
| Exanthema | 1 | 2022 | 74 | 0.180 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2021 | 49 | 0.170 |
Why?
|
| Phytosterols | 1 | 2021 | 28 | 0.170 |
Why?
|
| Amyloidosis | 1 | 2022 | 71 | 0.170 |
Why?
|
| Herpesvirus 6, Human | 1 | 2021 | 54 | 0.170 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2021 | 45 | 0.170 |
Why?
|
| Humans | 41 | 2025 | 131759 | 0.170 |
Why?
|
| Bacteroides | 1 | 2021 | 37 | 0.170 |
Why?
|
| Intestinal Neoplasms | 1 | 2021 | 36 | 0.170 |
Why?
|
| Inflammation | 4 | 2021 | 1493 | 0.170 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 849 | 0.170 |
Why?
|
| Dipeptides | 1 | 2021 | 64 | 0.160 |
Why?
|
| Ileum | 1 | 2021 | 124 | 0.160 |
Why?
|
| Lymphangioma | 1 | 2020 | 23 | 0.160 |
Why?
|
| Bifidobacterium | 1 | 2021 | 66 | 0.160 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 34 | 0.160 |
Why?
|
| Liver Glycogen | 1 | 2020 | 21 | 0.160 |
Why?
|
| Interleukins | 1 | 2021 | 121 | 0.160 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 225 | 0.160 |
Why?
|
| Mice | 14 | 2022 | 18482 | 0.160 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 225 | 0.160 |
Why?
|
| Myocarditis | 1 | 2021 | 130 | 0.150 |
Why?
|
| Animals | 18 | 2023 | 34404 | 0.150 |
Why?
|
| Adolescent | 13 | 2025 | 20987 | 0.150 |
Why?
|
| Infant | 11 | 2024 | 13317 | 0.150 |
Why?
|
| Immunocompromised Host | 2 | 2018 | 313 | 0.150 |
Why?
|
| Neuroblastoma | 1 | 2025 | 557 | 0.150 |
Why?
|
| Child, Preschool | 10 | 2025 | 15051 | 0.150 |
Why?
|
| Granuloma, Giant Cell | 1 | 2019 | 12 | 0.150 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2021 | 835 | 0.150 |
Why?
|
| Intestine, Small | 1 | 2021 | 287 | 0.150 |
Why?
|
| Infliximab | 1 | 2019 | 66 | 0.150 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 257 | 0.140 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2018 | 9 | 0.140 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2018 | 13 | 0.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 329 | 0.140 |
Why?
|
| Invasive Fungal Infections | 1 | 2018 | 19 | 0.140 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2018 | 8 | 0.140 |
Why?
|
| Dacryocystitis | 1 | 2018 | 22 | 0.140 |
Why?
|
| Fat Emulsions, Intravenous | 2 | 2021 | 80 | 0.140 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2018 | 53 | 0.140 |
Why?
|
| Opportunistic Infections | 1 | 2018 | 72 | 0.140 |
Why?
|
| Trichosporon | 1 | 2017 | 5 | 0.140 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 37 | 0.140 |
Why?
|
| Probiotics | 1 | 2021 | 231 | 0.140 |
Why?
|
| Dendritic Cells | 1 | 2021 | 437 | 0.140 |
Why?
|
| Fungemia | 1 | 2017 | 22 | 0.140 |
Why?
|
| Granuloma | 1 | 2018 | 63 | 0.130 |
Why?
|
| Streptococcus gallolyticus subspecies gallolyticus | 1 | 2017 | 2 | 0.130 |
Why?
|
| Denys-Drash Syndrome | 1 | 2017 | 2 | 0.130 |
Why?
|
| WT1 Proteins | 1 | 2017 | 22 | 0.130 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 404 | 0.130 |
Why?
|
| Symbiosis | 1 | 2018 | 94 | 0.130 |
Why?
|
| Th1 Cells | 1 | 2018 | 156 | 0.130 |
Why?
|
| Female | 24 | 2025 | 71214 | 0.130 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2025 | 962 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 173 | 0.130 |
Why?
|
| Male | 22 | 2025 | 65274 | 0.130 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2017 | 32 | 0.130 |
Why?
|
| Filamins | 1 | 2017 | 26 | 0.130 |
Why?
|
| Diet Therapy | 1 | 2017 | 41 | 0.130 |
Why?
|
| Parenteral Nutrition | 2 | 2021 | 216 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 464 | 0.130 |
Why?
|
| Copper | 1 | 2017 | 74 | 0.130 |
Why?
|
| Bronchogenic Cyst | 1 | 2016 | 9 | 0.130 |
Why?
|
| Esophagogastric Junction | 1 | 2016 | 36 | 0.130 |
Why?
|
| Lacrimal Apparatus | 1 | 2018 | 126 | 0.130 |
Why?
|
| Sjogren's Syndrome | 1 | 2018 | 108 | 0.130 |
Why?
|
| Glucocorticoids | 1 | 2019 | 350 | 0.130 |
Why?
|
| Bilirubin | 1 | 2017 | 126 | 0.120 |
Why?
|
| Esophageal Diseases | 1 | 2016 | 33 | 0.120 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2017 | 77 | 0.120 |
Why?
|
| Fundoplication | 1 | 2016 | 70 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 234 | 0.120 |
Why?
|
| Telomerase | 3 | 2001 | 157 | 0.120 |
Why?
|
| Esophageal Achalasia | 1 | 2016 | 48 | 0.120 |
Why?
|
| Branchial Region | 1 | 2015 | 8 | 0.120 |
Why?
|
| Pharyngeal Muscles | 1 | 2015 | 10 | 0.120 |
Why?
|
| Oropharynx | 1 | 2015 | 31 | 0.120 |
Why?
|
| Pharyngeal Diseases | 1 | 2015 | 17 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 137 | 0.120 |
Why?
|
| Spermatocele | 1 | 2015 | 2 | 0.110 |
Why?
|
| Infant, Newborn | 6 | 2021 | 8594 | 0.110 |
Why?
|
| Blister | 1 | 2015 | 21 | 0.110 |
Why?
|
| Polyps | 1 | 2015 | 41 | 0.110 |
Why?
|
| Thoracic Wall | 1 | 2015 | 41 | 0.110 |
Why?
|
| Scrotum | 1 | 2015 | 30 | 0.110 |
Why?
|
| Biological Therapy | 1 | 2015 | 26 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2021 | 974 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 568 | 0.110 |
Why?
|
| Streptococcal Infections | 1 | 2017 | 248 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 242 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 580 | 0.110 |
Why?
|
| Iron | 1 | 2017 | 310 | 0.110 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 123 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2015 | 128 | 0.100 |
Why?
|
| Swine Diseases | 1 | 2014 | 40 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 114 | 0.100 |
Why?
|
| Cornea | 1 | 2018 | 566 | 0.100 |
Why?
|
| Hair Diseases | 1 | 2013 | 14 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1309 | 0.100 |
Why?
|
| Mast Cells | 1 | 2013 | 65 | 0.100 |
Why?
|
| Enteritis | 1 | 2013 | 52 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2017 | 401 | 0.100 |
Why?
|
| Sarcoma | 1 | 2015 | 211 | 0.100 |
Why?
|
| Microbiota | 2 | 2015 | 441 | 0.100 |
Why?
|
| Eosinophils | 1 | 2013 | 126 | 0.100 |
Why?
|
| Testis | 1 | 2015 | 413 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 135 | 0.090 |
Why?
|
| Eosinophilia | 1 | 2013 | 109 | 0.090 |
Why?
|
| Lung Transplantation | 1 | 2017 | 350 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2021 | 1948 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 463 | 0.090 |
Why?
|
| Graft Survival | 2 | 2024 | 466 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1790 | 0.090 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2013 | 84 | 0.090 |
Why?
|
| Skin | 1 | 2015 | 553 | 0.090 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 1912 | 0.090 |
Why?
|
| Feces | 1 | 2015 | 725 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2014 | 357 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 4685 | 0.090 |
Why?
|
| Ceramides | 2 | 2001 | 46 | 0.090 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2014 | 255 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2016 | 555 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 639 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 3416 | 0.080 |
Why?
|
| Argininosuccinic Aciduria | 2 | 2025 | 52 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 372 | 0.080 |
Why?
|
| Stem Cells | 1 | 2015 | 713 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 766 | 0.080 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 341 | 0.080 |
Why?
|
| DNA | 1 | 2014 | 1442 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2015 | 1087 | 0.070 |
Why?
|
| Interleukin-10 | 2 | 2021 | 185 | 0.070 |
Why?
|
| Immunosuppressive Agents | 2 | 2024 | 667 | 0.070 |
Why?
|
| Voriconazole | 2 | 2018 | 30 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1811 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2024 | 1235 | 0.070 |
Why?
|
| Soybean Oil | 2 | 2021 | 71 | 0.070 |
Why?
|
| Biomarkers | 3 | 2022 | 3407 | 0.070 |
Why?
|
| Fish Oils | 2 | 2021 | 82 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 496 | 0.060 |
Why?
|
| Immunity, Mucosal | 2 | 2018 | 90 | 0.060 |
Why?
|
| Retrospective Studies | 6 | 2024 | 17662 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 904 | 0.060 |
Why?
|
| Antifungal Agents | 2 | 2018 | 298 | 0.060 |
Why?
|
| Incidence | 2 | 2024 | 3349 | 0.060 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2025 | 66 | 0.060 |
Why?
|
| Cytokines | 2 | 2021 | 1348 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 1218 | 0.050 |
Why?
|
| Swine | 2 | 2021 | 1190 | 0.050 |
Why?
|
| Gangliosides | 1 | 2025 | 74 | 0.050 |
Why?
|
| CpG Islands | 2 | 2015 | 338 | 0.050 |
Why?
|
| Natural Killer T-Cells | 1 | 2025 | 95 | 0.050 |
Why?
|
| Allografts | 1 | 2024 | 209 | 0.050 |
Why?
|
| Diet, Western | 1 | 2023 | 20 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2022 | 25 | 0.050 |
Why?
|
| Endoglin | 1 | 2022 | 31 | 0.050 |
Why?
|
| Primates | 1 | 2023 | 83 | 0.050 |
Why?
|
| Prednisone | 1 | 2022 | 244 | 0.050 |
Why?
|
| Amoxicillin | 1 | 2022 | 118 | 0.050 |
Why?
|
| Cough | 1 | 2022 | 99 | 0.040 |
Why?
|
| Chest Pain | 1 | 2022 | 128 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2022 | 207 | 0.040 |
Why?
|
| Dyspnea | 1 | 2022 | 160 | 0.040 |
Why?
|
| Cell Line | 2 | 2018 | 2606 | 0.040 |
Why?
|
| Ileitis | 1 | 2021 | 10 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2001 | 137 | 0.040 |
Why?
|
| Emulsions | 1 | 2021 | 70 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2021 | 48 | 0.040 |
Why?
|
| Mucin-2 | 1 | 2021 | 39 | 0.040 |
Why?
|
| Fibrosis | 1 | 2023 | 416 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2022 | 259 | 0.040 |
Why?
|
| Transfection | 3 | 2014 | 960 | 0.040 |
Why?
|
| Hyperammonemia | 1 | 2021 | 60 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 4768 | 0.040 |
Why?
|
| Phenotype | 2 | 2023 | 4528 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 386 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 80 | 0.040 |
Why?
|
| Lymphatic System | 1 | 2020 | 19 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2014 | 1024 | 0.040 |
Why?
|
| Serotonin | 1 | 2021 | 212 | 0.040 |
Why?
|
| Antioxidants | 1 | 2023 | 336 | 0.040 |
Why?
|
| Ethanol | 1 | 2021 | 164 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12993 | 0.040 |
Why?
|
| Observer Variation | 1 | 2020 | 319 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2021 | 451 | 0.040 |
Why?
|
| Cysts | 1 | 2020 | 93 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 125 | 0.040 |
Why?
|
| Antibodies | 1 | 2001 | 358 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 156 | 0.040 |
Why?
|
| Drug Administration Routes | 1 | 2019 | 33 | 0.040 |
Why?
|
| Longevity | 1 | 2021 | 176 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 305 | 0.040 |
Why?
|
| Pyloric Antrum | 1 | 2019 | 63 | 0.040 |
Why?
|
| Young Adult | 2 | 2025 | 10099 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2019 | 63 | 0.040 |
Why?
|
| Lipopeptides | 1 | 2018 | 35 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 260 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 46 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1020 | 0.040 |
Why?
|
| Echinocandins | 1 | 2018 | 42 | 0.040 |
Why?
|
| Remission Induction | 1 | 2019 | 309 | 0.040 |
Why?
|
| Amphotericin B | 1 | 2018 | 90 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2018 | 61 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2018 | 3864 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 63 | 0.030 |
Why?
|
| Prevalence | 1 | 2025 | 2695 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2018 | 118 | 0.030 |
Why?
|
| Permeability | 1 | 2018 | 120 | 0.030 |
Why?
|
| Febrile Neutropenia | 1 | 2017 | 16 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2018 | 113 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2021 | 291 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2018 | 104 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 773 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2018 | 124 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2018 | 115 | 0.030 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2018 | 108 | 0.030 |
Why?
|
| Drug Eruptions | 1 | 2017 | 34 | 0.030 |
Why?
|
| RNA | 1 | 2001 | 531 | 0.030 |
Why?
|
| Colectomy | 1 | 2018 | 88 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2018 | 159 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2019 | 233 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 336 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2017 | 84 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2001 | 998 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 202 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 242 | 0.030 |
Why?
|
| Neutropenia | 1 | 2018 | 205 | 0.030 |
Why?
|
| Lung Neoplasms | 3 | 2001 | 1542 | 0.030 |
Why?
|
| Middle Aged | 3 | 2025 | 28892 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2014 | 1018 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 1398 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 1236 | 0.030 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2018 | 210 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 154 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2018 | 2569 | 0.030 |
Why?
|
| beta Catenin | 1 | 2017 | 209 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2018 | 542 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2015 | 25 | 0.030 |
Why?
|
| Animals, Suckling | 1 | 2015 | 52 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 728 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1518 | 0.030 |
Why?
|
| Exons | 1 | 2018 | 769 | 0.030 |
Why?
|
| Back | 1 | 2015 | 12 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 989 | 0.030 |
Why?
|
| Syndrome | 1 | 2018 | 1170 | 0.030 |
Why?
|
| Vomiting | 1 | 2015 | 105 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1170 | 0.030 |
Why?
|
| Family | 1 | 2018 | 593 | 0.030 |
Why?
|
| Epithelium | 1 | 2015 | 343 | 0.030 |
Why?
|
| Cholestenones | 1 | 2014 | 7 | 0.030 |
Why?
|
| Olive Oil | 1 | 2014 | 24 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2014 | 49 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 65 | 0.030 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2014 | 32 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 2783 | 0.030 |
Why?
|
| Homeostasis | 1 | 2018 | 714 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2015 | 156 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2015 | 158 | 0.030 |
Why?
|
| Plant Oils | 1 | 2014 | 34 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2991 | 0.030 |
Why?
|
| Airway Obstruction | 1 | 2015 | 177 | 0.030 |
Why?
|
| Cell Count | 1 | 2013 | 217 | 0.030 |
Why?
|
| Infant Formula | 1 | 2014 | 104 | 0.020 |
Why?
|
| Gene Order | 1 | 2013 | 82 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 670 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 228 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2013 | 200 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 496 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 578 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 419 | 0.020 |
Why?
|
| Adult | 2 | 2025 | 31700 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 595 | 0.020 |
Why?
|
| Endoscopy | 1 | 2013 | 284 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 439 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 605 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2221 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 886 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 500 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 1069 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 565 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 10961 | 0.020 |
Why?
|
| Premature Birth | 1 | 2014 | 414 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1502 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2565 | 0.020 |
Why?
|
| Time Factors | 2 | 2014 | 6280 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3616 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2969 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3460 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1861 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3916 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 6507 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 4683 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2001 | 1965 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2001 | 41 | 0.010 |
Why?
|
| Glucosylceramides | 1 | 2001 | 3 | 0.010 |
Why?
|
| Ubiquitins | 1 | 2001 | 39 | 0.010 |
Why?
|
| Daunorubicin | 1 | 2001 | 25 | 0.010 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2001 | 18 | 0.010 |
Why?
|
| Cholic Acids | 1 | 2001 | 16 | 0.010 |
Why?
|
| Genes, myc | 1 | 2001 | 95 | 0.010 |
Why?
|
| Half-Life | 1 | 2001 | 151 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 127 | 0.010 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2001 | 43 | 0.010 |
Why?
|
| Phosphatidylserines | 1 | 2001 | 46 | 0.010 |
Why?
|
| Glucosyltransferases | 1 | 2001 | 44 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2001 | 64 | 0.010 |
Why?
|
| G1 Phase | 1 | 2001 | 65 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7576 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2001 | 350 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 240 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2001 | 195 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 769 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2001 | 464 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1626 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2001 | 2003 | 0.010 |
Why?
|